Twist Bioscience shareholders approve 100M share increase, equity plan amendment

Twist Bioscience Corp

Shareholders approved increase in authorized common stock by 100,000,000 shares (Proposal Five).
Amendment and restatement of 2018 Equity Incentive Plan approved; 3,700,000 new shares reserved (Proposal Four).
Directors Nelson Chan, Robert Ragusa, Melissa Starovasnik re-elected as Class I directors.
Non-binding advisory vote on NEO compensation passed with 49.6M votes for; 1.2M against.
Officer exculpation amendment approved (46.5M for, 4.3M against) effective upon filing Certificate of Amendment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.